FDA Investigator Patricia A Brown

Patricia A Brown has conducted inspections on 161 sites in 1 countries as of 14 Feb 2005. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
161
Last Inspection Date:
14 Feb 2005
Investigator Role:
FDA Investigator
Redica ID:
100007421
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Patricia A Brown:
Alan P Kurtzberg, Alanna L Mussawwir Bias, Amanda S Zorn, Andrea J Schmidt, Andrew M Kolenc, Anita Narula, PhD, Anthony J Lagreca, Arie C Menachem, Barbara J White, Becky L Bhan, Betty Kay Baxter, Blake R Jensen, Bodenw, Brent W Higgs, Brittany R Laymon, Bryan J Love, Bryce A Hammer, Carla R Hinz, Caroline H Le, Carolyn J Cook, Chani Broner, PhD, Chet A Fitzgerald, Christin L Torres, Christine I Shaw, Christine L Williams, Christopher M Jenner, Cynthia Jim, CSO, Daniel J Lahar, Daniel Pst Laurent, David A Gonzalez, Debra L Curtis, Denicia L Hernandez, Dianna D Wardlow Dotter, Doris M Sachanandani, Edith M Gonzalez, Elaine G Stewart, Elisa J Beard, Eric S Myskowski, Erika V Butler, Erin P Conlin, Esther C Broner, PhD, Farhana Khan, Felicia M Orlando, Felix J Marrero, Francisco J Mendoza, Frank L Cordova, Frederick L Fricke, Gary C Pecic, Jr, George J Flynn, Gerard T Schneider, Gina M Scholze, Ginger M Sykes, Grace E Mcnally, Gwyn G Dickinson, Hanna L Potter, Haroon Vohra (NMI), Harry A Wilson, Hoa V Nguyen, Holly L Miller, Isabel Y Espinosa, Isaiah D Isakson, Ismael Garibay, James P Stallings, James R Montero, Jamie L Dion, Jamie L Port, Janet Pulver, Janice L Straight, Jennifer A Baker, Jennifer A Robinson, Jennifer L Wolfe, Jennifer M Pouget, Jennifer R Mathern, Jessica M Ector, Jessie E Morris, John A Gonzalez, Jonathan R Campos, Juan A Morales, Justin R Carr, Karen A Wolnik, Karen G Hirshfield, Karen Wolnik, Katherine Szestypalow, Kathleen A Watts, Kathleen S Tormey, Kathryn M Mogen, Keith C Littrell, Kelly D Moore, Kent C Faul, Kevin D Kallander, Khumo A Phake, Kimberley A Hoefen, Kristen E Szenderski, Larisa E Pavlick, Larry Gehring, Laura B Kennedy, Laura L Van Wagenen, Lavender M Huskey, Linda Cherry, Linda F Murphy, Linda M Cheny, Lori A Carr, Lourdes Andujar, Manuel A Moreno, Marc A Jackson, Jr, Margaret M Annes, Marie B Buen Bigornia, Marion W Nadeau, Mariza M Jafary, Marlene G Swider, Marsha L Mccauley, Martina E Lagrange, Mary F Bodick, Matthew A Johnson, Matthew J Hansen, Matthew R Dionne, Meredith A Lindsay, Michael A Charles, Michael E Maselli, Michael J Kuchta, Michael Kuchta, Michael L Zimmerman, Michael R Goga, Michael S Araneta, Monica J Wilkins, Nalini D Lebzelter, Nancy G Schmidt, Nathan M Jornod, Nathan R Moon, Nayan J Patel, Neira Acevedo Ramos, Nga T Ho, Nicholas R Nance, Olious D Evans, Oluwaseyi Ojinni, Omotunde O Osunsanmi, Patricia A Cortez, Patricia A Maestas, Patricia Brown, Paul J Teitell, Paul Z Balcer, Philip E Ake, Philip J Boston, Prabhu P Raju, Ramesh Raghavachari, Rebecca H Lee, Richard W Clark, Ricki A Chase, Robert Sharpnack, Roger F Zabinski, Roger L Farmer, Samantha E Rafferty, Santiago Gallardo Johnson, Secrist, Shererk, Sidney B Priesmeyer, Steve P Yost, Steve Y Rhieu, PhD, Steven O Gauthier, Susan L Young, Tara L Breckenridge, Tara L Greene, Teena H Aiken, Tenzin Jangchup, Teresa I Navas, Thaddeus M Steinke, Thai T Duong, Theressa B Smith, Thomas V Anderson, Toni L Morales, Tyler Q Potts, Wdouglas Rowe, William A Lanier, William D Boden, William J Leonard, William S Vitale, Zachary A Bogorad, Zachary L Miller, Zachary L Stamm, Zhong Li, PhD

Patricia A Brown's Documents

Publish Date Document Type Title
April, 2000 EIR Wright, John R D.O. Clin Inv - EIR, 2000-04-10
May, 2001 FDA 483 Response Curia New Mexico, LLC - Form 483R, 2001-05-30
May, 2003 FDA 483 Response Sandoz Incorporated - Form 483R, 2003-06-06
June, 2003 EIR Anesta LLC - EIR, 2003-06-05
July, 2002 FDA 483 Navajo Manufacturing Company - Form 483, 2002-07-10
May, 2002 EIR Duboff, Eugene A Md Clin Inv - EIR, 2002-05-28
May, 2002 FDA 483 Duboff, Eugene A Md Clin Inv - Form 483, 2002-05-28
October, 2000 EIR Sandoz Incorporated - EIR, 2000-10-11
May, 2003 EIR Sandoz Incorporated - EIR, 2003-05-14
June, 2003 FDA 483 Response Anesta LLC - Form 483R, 2003-06-23
December, 2004 FDA 483 Sandoz Incorporated - Form 483, 2004-12-09
December, 2000 FDA 483 Upsher-Smith Laboratories, LLC - Form 483, 2000-12-19
April, 2002 EIR Sandoz Incorporated - EIR, 2002-04-23
May, 2001 EIR Curia New Mexico, LLC - EIR, 2001-05-17
June, 2003 FDA 483 Anesta LLC - Form 483, 2003-06-05
October, 2003 EIR Sandoz Incorporated - EIR, 2003-10-29
May, 2001 FDA 483 Curia New Mexico, LLC - Form 483, 2001-05-17
August, 2003 FDA 483 TMJ Medical, LLC - Form 483, 2003-08-11
May, 2002 FDA 483 Response Duboff, Eugene A Md Clin Inv - Form 483R, 2002-05-28
October, 2000 FDA 483 Sandoz Incorporated - Form 483, 2000-10-11
August, 2002 EIR Becton Dickinson and Company - EIR, 2002-08-05
May, 2003 FDA 483 Sandoz Incorporated - Form 483, 2003-05-14
April, 2002 FDA 483 Sandoz Incorporated - Form 483, 2002-04-23

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more